FDA’s Califf shares priority list with agency staff

Combatting misinformation about science and responding to the ongoing COVID-19 pandemic are the top priorities for Robert Califf as he retakes the helm of the US Food and Drug Administration (FDA).

Califf’s priorities were outlined in a 17 February memo to FDA staff, as well as on his new official Twitter feed (@DrCaliff_FDA). Califf was as confirmed as commissioner for the second time on 15 February by a narrow win in a 50-46 vote and sworn in two days later. Califf, a cardiologist, previously headed FDA during the final year of the Obama administration and is a founding director of the Duke Clinical Research Institute (Related: Senate confirms Califf as FDA commissioner, Regulatory Focus, 15 February 2022).